OQS
ATYR

Occudo Quantitative Strategies’s aTyr Pharma ATYR Stock Holding History

Occudo Quantitative Strategies’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,826
Closed -$36.7K – 1003
2024
Q3 		$36.7K Buy
+20,826
New +$37.9K 0.01% 667
2023
Q3 		– Sell
-54,892
Closed -$119K – 1358
2023
Q2 		$119K Buy
54,892
+42,970
+360% +$93.8K 0.01% 910
2023
Q1 		$25K Buy
+11,922
New +$26.1K ﹤0.01% 865

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Occudo Quantitative Strategies's ATYR Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of aTyr Pharma (ATYR) in Q4 2024, closing a stake of 20,826 shares — an estimated $36.7K sold.

Occudo Quantitative Strategies first reported a position in ATYR in Q1 2023 and held it in 3 quarters. The position peaked at $119K in Q2 2023. 77 funds tracked by Wall St. Rank hold ATYR as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining aTyr Pharma position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 20,826 aTyr Pharma shares in Q4 2024, an estimated $36.7K.
  • Occudo Quantitative Strategies first reported a position in aTyr Pharma in Q1 2023 and held it in 3 quarters.
  • Occudo Quantitative Strategies's aTyr Pharma position peaked at $119K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.